US Stock MarketDetailed Quotes
MNPR Monopar Therapeutics
- 19.4000
- -0.7000-3.48%
Close Nov 25 16:00 ET
- 18.5700
- -0.8300-4.28%
Post 20:01 ET
102.39MMarket Cap-9797P/E (TTM)
20.6285High18.6700Low88.81KVolume20.3000Open20.1000Pre Close1.72MTurnover3.56%Turnover RatioLossP/E (Static)5.28MShares38.500052wk High20.70P/B48.45MFloat Cap1.400052wk Low--Dividend TTM2.50MShs Float240.0000Historical High--Div YieldTTM9.74%Amplitude1.3695Historical Low19.3440Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Monopar Therapeutics Stock Forum
Cash and Net Loss
Cash and cash equivalents as of September 30, 2024, were $6.0 million. As noted above, the Company completed a registered public offering on October 30, 2024 that yielded net proceeds to the Company of approximately $17.7 million, after deducting placement agent fees and other estimated offering expenses.
Monopar project...
can anyone tell me which stock should I buy to get profit because the onse I've been had they're only giving return of 4 to 5%
$Monopar Therapeutics (MNPR.US)$
$Aurora Innovation (AUR.US)$
and $Grindr (GRND.US)$
are also boosting portfolios….
and
and
and
are also doing ok (beyond the obvious $Tesla (TSLA.US)$ , $NVIDIA (NVDA.US)$ and $MicroStrategy (MSTR.US)$ .
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
No comment yet